Theme: Theme: "Comprehensive Overview of What Personalized Medicine Means Today"
PERSONALIZED MEDICINE 2022
ME Conferences gladly invites all attendees from across the world to join the "10th International Conference on Predictive, Preventive, and Personalized Medicine & Molecular Diagnostics," which is going be scheduled on June 20 ,2022 | Webinar.
This is an excellent opportunity to go further into and strengthen compelling arguments in the field of personalised medicine. This will be an excellent opportunity to meet delegates, keynote speakers, university students, scientists, professors, cardiologists, nurses, pharmacists, Nano technologists, directors, and business delegates at a webinar to exchange scientific ideas and experiences in a unique environment, as well as to share your thoughts and suggestions with all participants. The conference's major goal is to discuss the most up-to-date guidelines, practise patterns, and solutions in genomic analysis, cancer therapies, and molecular diagnostics.
Why to attend?
Prominent physicians and professors will deliver keynote addresses. All speakers, delegates, and students would receive certificates. Medical Institutions and Hospitals Deans/Chairs, Vice Deans and Vice Presidents Professors and students working in the fields of research, medicine, clinical trials and Delegates from the business world, Directors/Managers, and Business Intelligence Experts, as well as Departmental Managers. At this conference, you will get the opportunity to meet world-famous people. This is the ideal platform for international business and networking.
- Bio makers
- Nano technologists
- Personalized oncologists
- Genetic researchers
- Intelligence experts
- Departmental managers
- Students from universities
- Business delegates
- Vice presidents of hospitals
Track 1: Personalized oncology
Personalized oncology is evidence-based, personalised therapy that provides the correct care to the right cancer patient at the right time, resulting in verifiable improvements in outcomes and cost savings. The usage of biomarkers is at the heart of personalised oncology's answer. Biomarkers derived from tissue, serum, urine, or imaging must be authenticated, and physicians must stay current on oncology advances. The goal of personalised medicine is to understand about a person's genetic makeup and how their tumour grows. They also discovered that genetic testing allowed doctors to tailor treatment to each patient's needs, resulting in fewer side effects than typical therapies.
Track 2: Preventive medicine
The purpose of preventive medicine is to avoid disease by avoiding the occurrence of disease or by arresting disease and averting its effects after it has begun. Government entities, primary care physicians, and individuals who practise preventive medicine can all practise it. Many diseases have been conquered in the past by doing things for the individual. The current problem of preventive medicine is to inspire individuals to practise preventive medicine. For chronic illnesses, preventive medicine strategies are available, which include acting before disease develops and recognising and treating disease at an early stage. Preventive medications are used to aid in the treatment of sickness and the maintenance of good health.
- Chronic illnesses
Track 3: Cardiology and Cardiovascular medicine
The leading cause of death is cardiovascular disease. Human genetic and genomic research has made significant improvements in cardiovascular medicine. The genetic risk of coronary artery disease is still a mystery. The current state of customised medicine for cardiovascular illness and its potential will be discussed. "The appropriate treatment to the right patient at the right time" is the main goal of personalised medicine. Precision medicine's potential in cardiovascular medicine extends to all stages of disease progression, including risk prediction. Non-invasive diagnostic methods and symptom-based disease treatment are frequently used in cardiovascular medicine. Although the potential to use genomic data to better manage men and women with cardiovascular disease has been highlighted, gender concerns in precision medicine have not been completely investigated.
- Cardiology molecular
Track 4: Psychotherapy
Psychotherapy is a generic term for consulting with a psychiatrist about mental health issues. We learn about our current situation, moods, feelings, ideas, and behaviour during psychotherapy. Psychotherapy comes in various forms, but the two most common are psychodynamic therapy and cognitive behavioural therapy. The five primary types of psychotherapy are as follows:
- Psychoanalysis and psychodynamic therapy
- Behavior therapy
- Cognitive therapy
- Humanistic therapy
- Integrative or holistic therapy
Track 5: Personalized medicine for gastroenterology
Infectious disorders of the gastrointestinal tract and other organs involved in digestion, such as the oesophagus, stomach, biliary system, small intestine, rectum, and anus, are referred to as gastrointestinal cancer. Restriction, irregular bleeding, and other difficulties relating to the damaged organ are examples of symptoms. We strive to determine the physical makeup of the disease, the patient's genotype, and their exposure to environmental factors through personalised therapy.
- Gastrointestinal malignancy
- Viral hepatitis
Track 6: Treatment of genetic disorders
Treatments for genetic illnesses are based on a person's genes, with inherited metabolic errors being the most common. This is normally handled by a biochemical genetics specialist in collaboration with a primary care physician. Additional illnesses are responding to treatment as the pathophysiology of other hereditary ailments has been better understood. In some circumstances, novel medicines for multifactorial conditions discovered through genetic investigations are likely to be employed by primary care physicians. The principles of management of the illness are the most important knowledge of genetics and genomics.
- Enzyme replacement therapy
- Lysosomal storage disorders
Track 7: Personalized cancer medicine
The study of human genes as well as the genes found in various tumours is known as personalised cancer medicine. These investigations have aided in the development of more critical treatments. They've also used genetic data to build cancer diagnostics and prevention methods. Personalized medicine is based on your medical history, genetics, and disease kind. Genes provide instructions to your body's cells on how to grow and develop. Many tumours are linked to or affected by specific genes. Find out more about cancer and your genetic makeup. Precision medicine is another name for this technique. Other methods of cancer treatment may have more side effects than personalised cancer medicine. This is due to the fact that it is intended to be more particular.
- Multiplex genotyping
- Non-small-cell lung cancer
Track 8: Stem cell and cell therapy
Stem cell treatments, often known as regenerative medicine, use stem cells or their derivatives to promote the repair response of sick, damaged, or wounded tissue. When it comes to organ transplantation, why not employ cells instead of donor organs, A stem cell line is a collection of cells derived from a single stem cell and cultured in a laboratory. A stem cell line's cells continue to develop but do not differentiate into specialised cells. They are generally free of genetic defects and continue to produce new stem cells. A stem cell line's cells can be separated into groups and stored or shared with other researchers.
- Ischemic heart disease
- Stem cell
Track 9: Pharmacometabolomics
Pharmacometabolomics is a branch of metabolomics, which is concerned with the quantification and study of metabolites produced by the human body. It refers to the direct measurement of metabolites in a person's body fluids, as well as the visualisation or evaluation of pharmaceutical chemical metabolism in order to better understand a drug's pharmacokinetic profile. Pharmacometabolomics, on the other hand, can be used to monitor the effects of a pharmacological molecule on specific metabolic pathways by measuring metabolite levels after treatment. This gives a thorough map of pharmacological effects on metabolism as well as the pathways that are thought to be involved in the mechanism of treatment response variance.
Track 10: Artificial intelligence and digital medicine
Artificial intelligence has recently outperformed humans in various fields, and there is high expectation that AI will improve illness prevention, detection, diagnosis, and treatment in healthcare. While many fear that AI would disrupt occupations and the physician-patient relationship, we believe that AI can free up time for human-to-human connection and the application of emotional intelligence and judgement by automating numerous monotonous chores. Recent research on AI applications in healthcare paints a picture of a future in which healthcare delivery is more unified and human.
- Future of medicine
- Machine learning
- Neural networks
Track 11: Prostate cancer and therapeutic implications
Prostatic carcinoma is the most prevalent cancer in men, and it is frequently multifocal in nature. There is on-going debate concerning the most appropriate system of tumour categorization and grading, as well as the best curative therapy options. The biologic, pathologic, prognostic and therapeutic implications of recent advances in the pathogenesis of multifocal prostatic cancer. Because of the multimodality of prostate cancer, appropriate clinical staging is challenging, and multiple adjustments have been made to improve prognostic accuracy. The clinical importance of the T2 sub staging is debatable, despite the fact that the revision is an improvement over earlier methods. The impact of tumour multimodality and clonal heterogeneity on the oncologic efficacy of innovative focused ablative techniques is also examined.
- Prostate cancer
- Cancer stem cells
- Tumor xenotransplantation assay
- Gene sequencing
Track 12: Path of Biomarkers
A biomarker and sub-atomic markers are quantitative indicators of the severity or proximity of an infectious condition in medicine. A biomarker is, in general, anything that may be used as a marker of a specific disease state or other physiological condition of a living organism Drug-Diagnostic Co-Development. The Centre has evolved from projections based on traditional anatomic arranging frameworks to a coordinated methodology based on the tumor's hereditary cosmetics and the patient's genotype in the current era of stratified solution and biomarker-driven medicines.
- Exhaled breath condensate
- Healthy subjects
- Hydrogen peroxide
Track 13: Life Style Medicine
The use of lifestyle mediations in the treatment and management of infection is known as Life Medicine (LM). Type-2 Diabetes, Coronary Heart Disease, Hypertension, Obesity, Insulin Resistance Syndrome, Osteoporosis, and cancer prevention are just a few of the chronic diseases for which LM is becoming the preferred way for prevention and treatment. Include Aerobic and Resistance training for diabetic patients, as well as sleep and infection prevention, intrinsic inspiration, and commitment to wellness habits.
- A new medical paradigm
- Chronic disease
Track 14: Advances in Molecular Diagnostics
Personalized Medicine is a new type of medicine that uses an individual's genetic profile to guide decisions about disease prevention, diagnosis, and treatment. Information about a patient's genetic profile can help experts choose the best possible prescription or treatment and manage it using the correct measurement or prescribed course of medical treatment. Diabetes-related illness: risk assessment and management, Personalized pharmaceuticals: New processes and financial implications, Implications of personalised prescriptions in HIV therapy, Applications of tailored drugs in rare diseases, and relocation medicine.
- Central nervous system infections
- Molecular diagnostics
Track 15: Market Strategies & Challenges in Personalized Medicine
P4 Medicine is a plan to use biotechnology to significantly improve the quality of human life. P4 Medicine is a phrase coined by academic Leroy Hood that stands for "predictive, preventive, personalised, and molecular medicine." The purpose of P4 Medicine is that, over the next 20 years, biotechnology will change restorative treatment to focus on a man's well-being rather on a patient's infection. Internal medicine, sometimes known as general medicine in Commonwealth nations, is a medical specialty that deals with the prevention, diagnosis, and treatment of adult illnesses. The term "crisis solution" refers to a medical specialty that involves monitoring adult and paediatric patients with severe illnesses or wounds that require immediate medical attention.
- clinical adoption
- integration into healthcare
- patient empowerment
- personalized-medicine education
Track 16: Genomics & Personalized Medicine
Genomics is a method of controlling inherited traits. To group, collect, and break down the capacity and structure of genomes, researchers use recombinant DNA, DNA sequencing tools, and bioinformatics. Propels in genomes have sparked an uprising in disclosure-based research to see even the most complicated organic frameworks, such as the brain. Attempts to determine the entire DNA grouping and human genome variation of life forms, as well as fine-scale hereditary mapping, are all part of this field. Intragenic miracles, such as heterosis, epistasis, pleiotropic, and other correlations in the centre of loci and all inside the genome, are also investigated in this subject, as well as met genomics.
- Genomic medicine
- Healthcare delivery
- Personalized medicine
Track 17: Genetics of Ebola Outbreak
Organize an Ebola infection investigation. The Ebola infection (EBO) genome indicates that it is sorted out also to rhabdoviruses and paramyxoviruses, and is for all intents and purposes the same as the Marburg infection (MBG). In the ebb and flow flare-up in Africa, researchers used genomic sequencing advances to identify the origin place and trace transmission of the Ebola infection.
- Ebola haemorrhagic fever
- Ebola virus
Track 18: Nanotechnology: Future of Personalized Medicine
The control of matter on a nuclear, atomic, and supramolecular scale is known as nanotechnology ("nanotech"). The earliest, broad depiction of nanotechnology alluded to the specific mechanical goal of precisely regulating particles and atoms for the development of macro scale products, currently known as sub-atomic nanotechnology. Nanopharmaceutical applications, cell-based therapies in nanotechnology and biotechnology, molecular systems are the techniques and instruments.
- Personalized health
- Precision medicine
Track 19: Personalized Drug Therapy
The personalised drug is a branch of medicine that entails predicting the possibility of illness and putting in place preventive measures with the objective of either keeping the illness at bay or completely reducing its impact on the patient (for example, by avoiding mortality or constraining dreariness). New born screening, diagnostic testing, medical bioinformatics, prenatal testing, carrier testing, and preconception testing are some of the methods and techniques used. Infant screening is a public health initiative that aims to test babies shortly after conception for a variety of disorders that are curable but not clinically evident throughout the infant age. Prenatal testing: Before a hatchling or developing life is conceived, prenatal testing is used to look for illnesses and diseases.
- Personalized drug treatment
Track 20: Immunology Infectious Disease
The study of how the immune system reacts to infectious agents, as well as how infectious agents interact with and affect the immune system is known as immunology infectious illness. Many immune system components are organic and are not linked to any one organ, but rather circulate in many tissues throughout the body. Immunotherapy is a new type of cancer treatment that harnesses the immune system's natural abilities to fight cancer. Because the immune system has distinct characteristics. These treatments may have more potential than current treatments when it comes to combating cancer more effectively.
- congenital infection
- Immunology Infectious Disease
- Personalized Drug Therapy
- Personalized oncology
- Preventive medicine
- Cardiology and Cardiovascular medicine
- Personalized medicine for gastroenterology
- Treatment of genetic disorders
- Personalized cancer medicine
- Stem cell and cell therapy
- Artificial intelligence and digital medicine
- Prostate cancer and therapeutic implications
- Path of Biomarkers
- Life Style Medicine
- Advances in Molecular Diagnostics
- Market Strategies & Challenges in Personalized Medicine
- Genomics & Personalized Medicine
- Genetics of Ebola Outbreak
- Nanotechnology: Future of Personalized Medicine
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
|Conference Date||June 20-20, 2022|
|Sponsors & Exhibitors||
|Speaker Opportunity Closed|
|Poster Opportunity Closed||Click Here to View|
All accepted abstracts will be published in respective Our International Journals.
- Journal of Pharmacogenomics & Pharmacoproteomics
- Translational Medicine
- Molecular and Genetic Medicine
Abstracts will be provided with Digital Object Identifier by